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Summary: We report the existence of a Msp I restriction fragment length polymorphism in the first intron
of the apolipoprotein A-I gene that is different from the one described by Seilhamer et al. (DNA 3, 309
(1984)). Size coniparispn of the newly discovered Msp I fragment with a restriction map of the apolipoprotein
A-I gene revealed that most likely the cutting site at the 5'-end of the normally seen 673 bp fragment is lost
giving rise to the observed 719 bp Mspl fragment. Based on analyses of 136 DNAs of healthy and non-
related caucasians the allelic frequency was determined to be 0.06. The observed Msp I genotype frequencies
are in Hardy-Weinberg eq^iilibrium,
^I5Ljanjtherisjc:fortlie<levdopinentofpremature
In recent years epidemiologic studies have clearly atherosclerosis (1). Coexistence of reduced HDLcon-
demonstrated a reverse relationship between the centrations and frequent occurrence of myocardial
plasma concentration of high density lipoproteins infarctions has been observed in many families (2, 3).
J. Clin. Chem. Clin, Biochem. / Vol. 25,1987 / No. 3
132 Funke et al.: A new Msp I restriction fragment length polymorphism in the apolipoprotein A-I gene
Thus, the risk for the development of atherosclerosis
may in many cases be related to alterations in the
genes controlling HDL metabolism.
Restriction fragment length polymorphisms have fre-
quently been used in assessing the structural hetero-
geneity of genes (4). Furthermore they have been
used in linkage studies (4, 5), äs markers for the
detection of disease (6, 7), äs tracers for the identifica-
tion of alleles in pedigree analyses (8), and in deter-
mining the clonal origin of tumours (9).
To date seven restriction fragment length polymor-
phisms (10 — 12) have been identified within the genes
for apolipoproteins A-I, C-III, and A-IV which are
located next to each other within a 15 kb DNA frag-
ment (13) in the region Ilql3-qter on chromosome
11 (14, 15).
The identification of an additional polymorphism
within the apolipoprotein A-I/C-III/A-IV gene clus-
ter, which we. report here, makes this gene locus more
informative for genetic analyses.
an additional wash with ethanol (volume fraction 0.7) the
precipitate was dried in a Speed-Vac concehtrator. The pellet
,was resolubilized in 1.5 ml Tris/EDTA buffer (10 mmol/1 Tris-
Cl pH 7.6, l mmol/l Na2 EDTA). Five microlitres of an RNase
A (Boehringer, Mannheim, FRG) solution (10 g/l RNase A, 10
mmol/1 Tris-Cl pH 7.5, 15 mmol/1 NaCl) was added and the
mixture was incubated at 37 °C for 2-18'h. Proteinase K
(Boehringer, Mannheim, FRG) was added to give a final con-
centration of 170 mg/1 and incubation was carried out overnight
at 48 °C. Extraction, precipitation and drying were done äs
described above.
The pellet was resohibilized in sterile water and the concentra-
tion was determined by measuring the absorbance at 260 nm.
The total yield from 25ml blood was 400-800 g DNA.
Virtually all DNA had a fragment length greater than 23 kb.
Southern blot
Genomic DNA (6 g) was cut with the restriction endonuclease
Msp I (Boehringer Mannheim, FRG) following the recommen-
dations of the enzyme supplier. Electrophoresis was done in a
12 g/l agarose gel (Agarose NA; Pharmacia, Freiburg, FRG)
in tris/acetate bufifer supplemented with 0.5 mg/1 ethidium
bromide. The DNA was transferred to nitrocellulose paper
(BA 85; Schleicher & Schüll, Dassel, FRG) by the procedure
of Southern (17) using 12x SSC (Ix SSC = 0.15 mol/1 NaCl,
15 mmol/1 sodium citrate pH 7.0). DNA was fixed on the
nitrocellulose by baking at 80 °C for 2 h.
Materials and Methods
Leukocyte Isolation
Bloo'd (25 ml) was collected in a syringe prefilled with l ml of
0.5 mol/1 Na2 EDTA pH 8.0 äs an anticoagulant. Leukocytes
were prepared by a modification of the method described by
Gauireau et al. (16). Briefly, 25 ml Na2 EDTA-containing blood
was centrifuged at 2000g for 15 min. The supernatant plasma
1
 was discarded and the tube was refilled to the original volume
with 0.15 raol/1 NaCl. This Suspension was mixed with an equal
volume of a solution containing 30 g dextran T 500 (Pharmacia,
Freiburg, FRG) and 9 g NaCl per liter, and taken up into a
50 ml syringe, which was then allowed to stand on its plunger
for 30 min to ailow the erythrocytes to settle. The supernatant,
containing the white cells, was centrifuged for 5 min at 2000 g.
Residual red cells contaminating the leukocyte pellet were lysed
by the addition of water. After 30 s isotonicity was restored by
the addition of 0.3 mol/1 NaCl and the leukocytes were pelleted
at 2000 g for 5 min.
Hybridization
Conditions for hybridization with apolipoprotein A-I cDNA
were exactly äs described by Law et al. (18). The cDNA (600 bp
Ava II fragment from pBL13AI, (10)) was radioiabelled by nick
translation using the nick translation kit from NEN (Dreieich,
FRG) following the supplier's instructions. The labeiled nucleo-
side triphosphate was [a-32P]dCTP at a specific activity of
29.6 PBq/mol (800 Ci/mmol). The nick transläted cDNA was
purified by chromatography on a 10 ml Sephadex G-50 Fine
column (Pharmacia, Freiburg, FRG) using Tris/EDTA buffer
äs mobile phase. Its specific activity was 0.4—1 l O8 counts ·
min"1 · g~ äs calculated by Cerenkov counting and assuming
a 100% recovery from the column.
The air-dried fiiters were wrapped in ultrathin plastic foil,
placed on a Kodak XAR 5 film between two Kodak X=Omatic
Regulär intensifying screens, and stored at — 70 °C for 1—4
days.
DNA isolation
DNA was prepared from leukocytes by a method similar to
the one reported by Geever et al. (7). Leukocytes were resus-
pended in 3 ml of a buffer containing 20 mmol/1 Tris-Cl (pH
7.9), l mmol/1 Na2 EDTA, 0.3 mol/1 sodium acetate, 2 g/l SDS1)
and proteinase K (170 mg/1). Incubation was at 48 °C for 12-
36 h.
Proteins were removed by three extractions with phenoi/chloro-
form/isoamylalcohol (25 + 24 + 1) followed by three extrac-
tions with chloroform/isoamylalcohol (24 + 1) alone. DNA
was precipitated by the addition of 2.5 volumes of ice-cold
ethanol. The DNA was pelleted at 2000 g for 5 min. After
0 Abbreviations used: Bp = base pair, cDNA = complemen-
tary DNA, IVS = intervening sequence, RNase A = ribo-
nuclease A, SDS = sodium dodecylsulphate, Mspl = a
restriction endonuclease from Moraxella species with the
target sequence CJCGG.
Results
DNA was isolated from leukocytes of medical stu-
dents of the University of Münster and assayed for
the presence of the Msp I polymorphism described
by Seilhamer et al. (10). In some DNAs the presence
of a previously unidentified Msp I fragment was ob-
served which migrated just above the regularly seen
673 bp fragment (fig. 1). Comparison of the newly
discovered fragment with a restriction map of the
apolipoprotein A-I gene suggested that this fragment
was generated by the loss of the cutting site at the
5'-end of the regulär 673 bp fragment. The alternative
assumption that the loss of the cutting site occurs at
the 3'-end of this fragment can be ruled out, because
the expected 1.01 kb to 1.05 kb* fragment is absent.
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Fig. l Msp I polymorphisms within the apolipoprotein A-I
gene. The lower part shows a schematic drawing of the
coding Strand of the apolipoprotein A-I gene with boxes
representing exon sequences. The bar on top of the
boxes indicates the length of the cDNA used for hybrid-
ization. Normal Msp I cutting sites are indicated by
arrows. The presence of all cutting sites leads to the
detection of 0.67 kb and 1.08 kb Msp I fragments (allele
AI). If the Msp I site within intron 3 (IVS 3) is absent,
a 1.76 kb fragment is generated (allele A2). The absence
of the Msp I site within intron l creates a 0.72 kb poly-
morphic fragment (allele A3). Individuais represented
in lane l, 3, and 6 are heterozygous for the A2 allele
(1.76 kb Msp I fragment), those represented in lanes 4
and 5 are heterozygous for the A3 allele (0.72 kb and
1.08 kb Msp I fragments). Lane 2 represents an indivi-
dual heterozygous for both the A2 and A3 alleles.
The generation of the 0.72 kb polymorphic fragment
by a small insertion was ruled out by the observation
of regulär size Stu I and Rsa I restriction fragments
(data not shown).
FoIIowing a proposal of the Committee on Human
Gene Mapping by Recombinant DNA Techniques
(19) the observed Msp I alleles are designated AI, A2
and A3 according to deereasing allelic frequencies,
with allele AI being characterized by the regulär l .08
kb and 0.67 kb Mspl fragments (allelic frequency
0.81), allele A2 by an 1.76 kb Msp fragment (allelic
frequency 0.13), and allele A3 by 0.72 kb and 1.08
kb Msp I fragments (allelic frequency 0.06).
Mendeh&n inheritance of the newly.discovered A3
allele was documented by the ideritification of an
individual who is heterozygous for both the A2 and
A3 alleles (fig. 1). Family analysis showed that this
person had inherited allele A2 (1.76 kb Mspl frag-
ment) from his mother and allele A3 (0.72 kb and
1.08 kb Msp I fragments) from his father (fig. 2).
The absence of both polymorphic Msp I cutting sites
from the same DNA molecule would generate a 1.81
kb restriction fragment which may not be thoroughly
Ö
CD
Fig. 2. Pedigree of a family with Msp I polymorphisms in the
apolipoprotein A-I gene.
El O Msp I (1.7) heterozygotes
D © Msp I (0.72) heterozygotes
resolved from the 1.76 kb fragment with Standard
electrophoresis procedures. However, using Msp I/
Apa I and Msp I/Bcl I double digests, the existence
of an allele characterized by the simultaneous absence
of both Msp I sites could not be demonstrated.
From the analysis of DNA from 136 healthy and
non-related caucasians the allelic frequency of the A3
allele was found to be 0.06. In the same group the
A2 allele had an allelic frequency of 0.13, which is in
agreement with the data reported by Coleman and
coworkers (12).
Observed and expected AI and A3 allele frequencies
were compared by employing a 2 test. They were
found to be in Hardy-Weinberg equilibrium ( 2 =
0.463, f = l, p > 0.05).
Discussion
The existence in the apolipoprotein A-I gene of a
second Msp I polymorphism has been demonstrated.
From restriction map analysis it appears likely that
the new polymorphism is based on the loss of a
regulär Msp I cutting site. A base exchange äs well äs
the methylation of a cytosine within the recognition
sequence could provide the structural basis for the
generation of the 0.72 kb fragment of the A3 allele.
Msp I is sensitive to a meCCGG methylation, but not
to the more frequently observed CmeCGG methyla-
tion (20). As CpG dinucleotide sequences have been
demonstrated to be hot spots for C to T transitions
(21), it can be hypothesized that this base exchange
may be the underlying structural basis for the newly
observed polymorphism. A definite decision, how-
ever, can only be made after sequence analysis.
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The new Msp I polymorphism described here helps
to increase the degree of polymorphism in the apoli-
poprotein A-I/C-III/A-IV gene cluster and thus
makes this locus a better marker and a better tool
for analysing disorders of high density lipoprotein
metabolism.
The Information content of all restriction fragment
length polymorphisms in the apolipoprotein A-I/C-
III/A-IV gene cluster is sufficient to use this gene
conaplex äs a DNA marker locus for genetic linkage
studies äs praposed by Botstein et al. (4).
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